Risk factors for central nervous system (CNS) metastases in patients with stage I-III breast cancer

被引：0
|
作者：
Neciosup, S. P.
Gomez, H. L.
Cruz, W. R.
Doimi, F. F.
Pinto, J. A.
Cotrina, J. M.
Suazo, J. F.
Carlos, V. E.
Mauricio, L.
Vallejos Sologuren, C.
机构：
[1] Inst Nacl Enfermedades Neoplas, Lima, Peru
[2] GECOPERU, Lima, Peru
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.1063
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1063
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Risk factors for outcome in Hispanic patients with breast cancer with central nervous system (CNS) metastases
    Schwarz, L. J.
    Vidaurre, T.
    Neciosup, S. P.
    Pinto, J. A.
    Ferreyros, G.
    Gomez, H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [2] Risk and tropism of central nervous system (CNS) metastases in patients with stage II and III cutaneous melanoma
    Johannet, Paul
    Simons, Morgan
    Qian, Yingzhi
    Azmy, Nadine
    Mehnert, Janice M.
    Weber, Jeffrey S.
    Zhong, Judy
    Osman, Iman
    [J]. CANCER, 2022, 128 (20) : 3620 - 3629
  • [3] INDEPENDENT FACTORS FOR POOR PROGNOSIS IN YOUNG PATIENTS WITH STAGE I-III BREAST CANCER
    Eric, Ivan
    Eric, Anamarija Petek
    Koprivcic, Ivan
    Babic, Marko
    Pacaric, Stana
    Trogrlic, Bojan
    [J]. ACTA CLINICA CROATICA, 2020, 59 (02) : 242 - 251
  • [4] Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)
    Pestalozzi, BC
    Zahrieh, D
    Price, KN
    Holmberg, SB
    Lindtner, J
    Collins, J
    Crivellari, D
    Fey, MF
    Murray, E
    Pagani, O
    Simoncini, E
    Castiglione-Gertsch, M
    Gelber, RD
    Coates, AS
    Goldhirsch, A
    [J]. ANNALS OF ONCOLOGY, 2006, 17 (06) : 935 - 944
  • [5] The risk and tropism of central nervous system metastases (CNS) in patients with stage II cutaneous melanoma.
    Johannet, Paul
    Kim, Min Jae
    Call, Melissa
    Gulati, Nicholas
    Zhong, Judy
    Mehnert, Janice M.
    Osman, Iman
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [6] Systemic Therapy in the Setting of Central Nervous System (CNS) Metastases in Breast Cancer
    Chao Y.L.
    Anders C.K.
    [J]. Current Breast Cancer Reports, 2017, 9 (4) : 217 - 226
  • [7] Adjuvant treatment results and prognostic factors in patients with stage I-III operated breast cancer
    Izmirli, Mustafa
    Donmez Yilmaz, Binnur
    Alan, Omur
    Yalciner, Mehmet
    Berberoglu, Elif
    Unsal, Mustafa
    [J]. TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2006, 21 (02): : 72 - 80
  • [8] PEMETREXED FOR PATIENTS WITH CENTRAL NERVOUS SYSTEM (CNS) METASTASES
    Grimm, S. A.
    Patel, J.
    Cianfrocca, M.
    Gradishar, W.
    Mulcahy, M.
    Kaklamani, V.
    Von Roenn, J.
    Kennedy, S.
    Raizer, J.
    [J]. NEURO-ONCOLOGY, 2008, 10 (06) : 1115 - 1115
  • [9] PEMETREXED FOR PATIENTS WITH CENTRAL NERVOUS SYSTEM (CNS) METASTASES
    Kumthekar, Priya U.
    Grimm, Sean A.
    Avram, Michael
    Patel, J.
    Kaklamani, V.
    McCarthy, Katie
    Cianfrocca, Mary
    Gradishar, William
    Mulcahy, M.
    Von Roenn, J.
    Helenowski, I.
    Rademaker, A.
    Raizer, J.
    [J]. NEURO-ONCOLOGY, 2011, 13 : 62 - 62
  • [10] GUIDELINES FOR THE MANAGEMENT OF CENTRAL NERVOUS SYSTEM (CNS) METASTASES IN WOMEN WITH SECONDARY BREAST CANCER
    Boyle, F.
    Anderson, K.
    Nelson, A.
    Care, O.
    Chynoweth, J.
    Zorbas, H.
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 52 - 52
12345